openPR Logo
Press release

Global Epilepsy Monitoring Device Market Growing at a CAGR of 8.83% to Reach USD 1272.2 Million By 2030 | Infinium Global Research

Global Epilepsy Monitoring Device Market Growing at a CAGR

Infinium Global Research's recent report illuminates the expanding landscape of the Epilepsy Monitoring Device Market, offering an in-depth analysis of segments, sub-segments, and regional dynamics shaping this burgeoning industry. The comprehensive study delves into the impact of drivers, restraints, and macro indicators on both global and regional fronts, presenting a compelling overview of trends, forecasts, and dollar values. The global epilepsy monitoring device market was valued at USD 661.6 Million in 2022 and is expected to reach USD 1272.2 Million by 2030 and grow at a CAGR of 8.83% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/18084

The global epilepsy monitoring device market is poised to witness a significant growth trajectory, projected to surge at a noteworthy Compound Annual Growth Rate (CAGR) of 8.83% between 2023 and 2030 in terms of value. This upsurge is attributed to the critical role played by epilepsy monitoring devices in diagnosing brain abnormalities. Real-time monitoring and seizure detection have become increasingly crucial in recent years.

According to the Centers for Disease Control and Prevention, approximately 3.4 million Americans, including 470,000 children, live with epilepsy. Alarmingly, about 35% do not respond to medication, necessitating advanced monitoring solutions. The market has responded with innovative devices like mHealth wearables such as the SmartWatch Inspyre™ for the Apple Watch, designed to track epileptic seizures and alert care teams, significantly enhancing patient safety.

The prevalence of epilepsy, affecting around 50 million individuals globally, poses a significant burden in terms of disability, stigma, mortality, comorbidities, and costs. This burden drives the escalating demand for epilepsy monitoring devices. Furthermore, increased awareness about epilepsy and the surge in device usage propel market growth. However, diagnostic challenges remain a hurdle due to the diversity in seizure types and appearances, complicating accurate diagnosis.

Geographically, North America holds a dominant position in the epilepsy monitoring device market, attributed to advanced healthcare facilities and a robust healthcare infrastructure. With an estimated average incidence of 150,000 cases annually in the U.S., the growing prevalence further fuels market growth in this region. Conversely, Asia Pacific emerges as the fastest-growing region due to its large population with epilepsy prevalence.

Key players in the global epilepsy monitoring device market include Medtronic plc, Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, LivaNova, PLC, St. Jude Medical, Inc., Empatica Inc., and Boston Scientific Corporation.

Epilepsy, classified as a common neurological disease globally, affects around 50 million individuals. The International League Against Epilepsy (ILAE) suggests that genetic factors contribute to approximately 30% of epilepsy cases, with idiopathic epilepsy being prevalent in cases where no cause can be identified.

The absence of a cure for epilepsy promotes innovation among monitoring device manufacturers. These devices serve as vital tools for healthcare professionals in quantifying seizures, aiding in more reliable treatment decisions. Advanced monitoring devices equipped with video capabilities offer improved seizure visualization, particularly beneficial for individuals with infrequent or varied seizure types, and those lacking access to specialist care.

Despite technological advancements, challenges persist in accurately diagnosing epilepsy due to limited opportunities to observe seizures and diverse seizure appearances. The continuous quest for more advanced, continuous, and accurate monitoring options by healthcare professionals drives the demand for enhanced monitoring devices.

The U.S. Food and Drug Administration's approval of a mHealth wearable capable of detecting epileptic seizures and immediately alerting care teams underscores the ongoing technological advancements revolutionizing the field. These innovations, including bracelets, mattress devices, and smartwatches, enable real-time seizure recording by caregivers and family members.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/18084

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Epilepsy Monitoring Device Market Highlights

2.2. Epilepsy Monitoring Device Market Projection

2.3. Epilepsy Monitoring Device Market Regional Highlights

Chapter 3. Global Epilepsy Monitoring Device Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product

3.4.2. IGR-Growth Matrix Analysis by End User

3.4.3. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Epilepsy Monitoring Device Market

Chapter 4. Epilepsy Monitoring Device Market Macro Indicator Analysis

Chapter 5. Global Epilepsy Monitoring Device Market by Product

5.1. Conventional Devices

5.2. Wearable Devices

Chapter 6. Global Epilepsy Monitoring Device Market by End User

6.1. Clinics

6.2. Hospitals

6.3. Home Care Settings

6.4. Other End Users

Chapter 7. Global Epilepsy Monitoring Device Market by Region 2023-2030

7.1. North America

7.1.1. North America Epilepsy Monitoring Device Market by Product

7.1.2. North America Epilepsy Monitoring Device Market by End User

7.1.3. North America Epilepsy Monitoring Device Market by Country

7.2. Europe

7.2.1. Europe Epilepsy Monitoring Device Market by Product

7.2.2. Europe Epilepsy Monitoring Device Market by End User

7.2.3. Europe Epilepsy Monitoring Device Market by Country

7.3. Asia-Pacific

7.3.1. Asia-Pacific Epilepsy Monitoring Device Market by Product

7.3.2. Asia-Pacific Epilepsy Monitoring Device Market by End User

7.3.3. Asia-Pacific Epilepsy Monitoring Device Market by Country

7.4. RoW

7.4.1. RoW Epilepsy Monitoring Device Market by Product

7.4.2. RoW Epilepsy Monitoring Device Market by End User

7.4.3. RoW Epilepsy Monitoring Device Market by Sub-region

Chapter 8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Epilepsy Monitoring Device Market

8.2. Companies Profiles

8.2.1. Medtronic plc

8.2.2. Koninklijke Philips N.V.

8.2.3. Natus Medical Incorporated

8.2.4. Nihon Kohden Corporation

8.2.5. LivaNova, PLC

8.2.6. St. Jude Medical, Inc.

8.2.7. Empatica Inc.

8.2.8. Boston Scientific Corporation

Chapter 9. Appendix

9.1. Primary Research Findings and Questionnaire

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/18084

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Epilepsy Monitoring Device.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Epilepsy Monitoring Device Market Growing at a CAGR of 8.83% to Reach USD 1272.2 Million By 2030 | Infinium Global Research here

News-ID: 3295787 • Views:

More Releases from Infinium Global Research LLP

Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR 7.24%: Infinium Global Research
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends. The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections. To Know More Request a Sample of
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surpass USD 5.09 Billion By the End of 2030 with a Growing CAGR of 9.56% | Infinium Global Research
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420 Market Insight: The global Proprotein Convertase Subtilisin/Kexin Type 9 market,
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growing at a CAGR of 9.59% During Forecast Period 2023 - 2030 | IGR
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93 Market Insight: The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Billion By 2030 | Infinium Global Research
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Bill …
Infinium Global Research, a leading market intelligence firm, has released an extensive report delving into the dynamics and trends shaping the Global Botulinum Toxin Market. This comprehensive analysis spans both the global landscape and regional perspectives, providing invaluable insights into the market's trajectory, influencing factors, and growth projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/89 Market Insight: The global botulinum toxin market, valued at USD 10.02 billion in 2022, is

All 5 Releases


More Releases for Epilepsy

Epilepsy Market Synthesis and Opportunity Assessment 2030
Epilepsy - Market Insight, Epidemiology And Market Forecast -2030: This report delivers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Epilepsy market report provides current treatment practices, emerging drugs, Epilepsy market share of the individual therapies, current and forecasted Epilepsy market Size from 2017 to 2030 segmented
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve
World Congress on Epilepsy and Neuronal Synchronization
Inculcate the latent knowledge in Epilepsy and Neuronal synchrony May 14, 2018: Pulsus Group, host of World Congress on Epilepsy and Neuronal Synchronization, the Conference that discusses the Advanced diagnosis of Epilepsy. Epilepsy 2018 slated during October 15- 16, 2015 at London, UK will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Neurology, Neuropsychiatry & Neuropathology fields across the world. The Epilepsy conference scientific
Epilepsy Therapeutic Pipeline Market Review, 2026
Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain. It is one of the most common neurological conditions globally. Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered at least one epileptic seizure and is referred to a specialist, where a description of the
Epilepsy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Epilepsy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the
H2 Epilepsy Market Pipeline Review 2017
"The Report Epilepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in